Literature DB >> 15858802

Nontuberculous mycobacterial infection in young children with cystic fibrosis.

Charles R Esther1, Marianna M Henry, Paul L Molina, Margaret W Leigh.   

Abstract

Although nontuberculous mycobacteria (NTM) are recognized pathogens in adolescent and adult patients with cystic fibrosis (CF), the role of NTM in younger CF patients is not well-defined. To explore NTM infection in CF patients less than 12 years old, a retrospective review was performed. Prevalence was estimated from routine mycobacterial cultures of bronchoalveolar lavage (BAL) specimens collected over a 3-year period. NTM-positive cultures were obtained from 9 of 258 BALs collected from 7 of 114 different patients (5 months to 11 years of age). Further data were acquired from microbiological and clinical records of all pediatric patients with CF over a 10-year period. A total of 17 patients had at least one positive mycobacterial culture at less than 12 years of age, 5 of whom had positive cultures before age 5. The most commonly identified organisms were Mycobacterium avium-complex and Mycobacterium abscessus. Of the 17 patients, 10 met American Thoracic Society (ATS) microbiological criteria for mycobacterial disease, and 7 did not. The two groups did not differ with respect to age, gender, or presence of other respiratory pathogens. Patients who met ATS microbiological criteria for disease were more likely to have positive smears for acid-fast bacilli and grow Mycobacterium abscessus from culture. These patients also had a greater decline in lung function over time than patients who did not meet the microbiologic criteria. These data suggest that NTM represent a clinically significant pathogen, even in young patients with cystic fibrosis. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858802     DOI: 10.1002/ppul.20222

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  31 in total

1.  Molecular fingerprinting of Mycobacterium abscessus strains in a cohort of pediatric cystic fibrosis patients.

Authors:  Kathryn A Harris; Dervla T D Kenna; Cornelis Blauwendraat; John C Hartley; Jane F Turton; Paul Aurora; Garth L J Dixon
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Molecular typing of Mycobacterium abscessus based on tandem-repeat polymorphism.

Authors:  Y L Wong; C S Ong; Y F Ngeow
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

Review 3.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

4.  Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.

Authors:  Valerie Waters; Felix Ratjen
Journal:  Cochrane Database Syst Rev       Date:  2020-06-10

5.  Detection of rapidly growing mycobacteria in routine cultures of samples from patients with cystic fibrosis.

Authors:  Charles R Esther; Steven Hoberman; Jason Fine; Sonia Allen; Karissa Culbreath; Kyle Rodino; Alan Kerr; Peter Gilligan
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

6.  Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.

Authors:  Stacey L Martiniano; Marci K Sontag; Charles L Daley; Jerry A Nick; Scott D Sagel
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 7.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 8.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.

Authors:  Janice M Leung; Kenneth N Olivier
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

Review 9.  Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.

Authors:  Zarmina Ehsan; John P Clancy
Journal:  Future Microbiol       Date:  2015-11-17       Impact factor: 3.165

10.  Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis.

Authors:  Charles R Esther; Denise A Esserman; Peter Gilligan; Alan Kerr; Peadar G Noone
Journal:  J Cyst Fibros       Date:  2010-01-13       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.